Cardinal Health
Open
$192.96
Prev. Close
$192.92
High
$192.96
Low
$192.21
Market Snapshot
$48.19B
29.0
5.40
$222.28B
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Cardinal Health reported an 11% revenue increase to $60.9 billion and a 35% rise in non-GAAP diluted EPS to $3.17, enhancing its fiscal year 2026 outlook.
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Recently from Cashu

Cardinal Health Reports Strong Fiscal Start, Boosts Earnings Outlook Amid Strategic Growth Initiatives
Cardinal Health's Strong Fiscal Kickoff Driven by Pharma Solutions Cardinal Health has reported a robust start to fiscal 2025, driven predominantly by its Pharma and Specialty Solutions segment, which…

Cardinal Health's 2026 Report Details Strategic Shift in Therapy Administration for Better Patient Accessibility.
Cardinal Health unveils its latest report focusing on Advanced Therapies for 2026, marking a pivotal moment in the evolution of healthcare delivery. The report underscores a notable transition in the…
Cardinal Health's Resilience and Growth Amid Geopolitical Challenges and Leadership Changes
Cardinal Health's Resilience Amid Geopolitical Tensions Cardinal Health remains a robust player in the pharmaceutical distribution arena, continuing its operations largely insulated from global politi…
Cardinal Health Appoints Patricia A. Hemingway Hall as New Chair, Signaling Strategic Shift
Leadership Change Signals New Direction for Cardinal Health Cardinal Health inaugurates a new chapter with the appointment of Patricia A. Hemingway Hall as Chair of the Board, following the retirement…